Construct: ORF ccsbBroad304_01534
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF008710.1_s304c1, BRDN0000410710
- Derived from:
- ccsbBroadEn_01534
- DNA Barcode:
- None
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- ST3GAL3 (6487)
Vector Information:
- Vector Backbone:
- pLX_304
- Pol II Cassette 1:
- PGK-BlastR
- Pol II Cassette 2:
- CMV-ccsbBroad304_01534
- Selection Marker:
- BlastR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_006279.5 | 100% | 100% | |
| 2 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002113.1 | 100% | 100% | |
| 3 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174964.4 | 96.1% | 95.8% | 119_163del |
| 4 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174969.4 | 95.7% | 95.4% | 118_119ins48 |
| 5 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270459.2 | 92% | 92% | 743_744ins90 |
| 6 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270460.2 | 91.7% | 91.7% | 209_210ins93 |
| 7 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174968.5 | 87.4% | 87.4% | 210_371del |
| 8 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174963.5 | 84.4% | 84.2% | 119_163del;255_416del |
| 9 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001350620.2 | 83.7% | 77.1% | 1039_1234del;1302_1303insTGATCTAAGCAGTGGCATC |
| 10 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174971.5 | 83.6% | 83.4% | 118_119ins48;162_323del |
| 11 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001350619.2 | 80.9% | 74.4% | 119_163del;1084_1279del;1347_1348insTGATCTAAGCAGTGGCATC |
| 12 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_006710827.4 | 80% | 73.3% | 118_119ins48;991_1186del;1254_1255insTGATCTAAGCAGTGGCATC |
| 13 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541974.2 | 74.5% | 68.9% | 210_371del;1201_1396del;1464_1465insTGATCTAAGCAGTGGCATC |
| 14 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174966.4 | 73.8% | 73.8% | 743_744ins294 |
| 15 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541973.2 | 73.4% | 66.8% | (many diffs) |
| 16 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002109.2 | 72.3% | 66.7% | (many diffs) |
| 17 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002120.1 | 71.4% | 71.4% | 0_1ins321 |
| 18 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002121.1 | 71.4% | 71.4% | 0_1ins321 |
| 19 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541976.2 | 71.3% | 65.5% | (many diffs) |
| 20 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541980.3 | 70.1% | 61% | (many diffs) |
| 21 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270461.3 | 69.6% | 69.3% | 118_119ins48;695_696ins294 |
| 22 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002110.1 | 64.6% | 50.9% | (many diffs) |
| 23 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001363573.2 | 64.5% | 64.5% | 210_371del;905_906ins294 |
| 24 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541981.2 | 62.3% | 62.1% | 119_163del;255_416del;950_951ins294 |
| 25 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541983.2 | 62.3% | 56.3% | 0_1ins282;757_952del;1020_1021insTGATCTAAGCAGTGGCATC |
| 26 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002116.1 | 62.3% | 56.3% | 0_1ins282;757_952del;1020_1021insTGATCTAAGCAGTGGCATC |
| 27 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001350621.2 | 62.1% | 54.9% | (many diffs) |
| 28 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002114.1 | 62.1% | 54.9% | (many diffs) |
| 29 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_017002115.1 | 62.1% | 54.9% | (many diffs) |
| 30 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270462.3 | 61.3% | 61% | 118_119ins48;161_162ins93;602_603ins294 |
| 31 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541987.2 | 59.4% | 53.4% | 0_1ins321;718_913del;981_982insTGATCTAAGCAGTGGCATC |
| 32 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541988.2 | 59.4% | 53.4% | 0_1ins321;718_913del;981_982insTGATCTAAGCAGTGGCATC |
| 33 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541984.2 | 57.5% | 56.1% | (many diffs) |
| 34 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541985.2 | 57.5% | 56.1% | (many diffs) |
| 35 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XM_011541986.3 | 57.5% | 56.1% | (many diffs) |
| 36 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XR_946743.2 | 55% | (many diffs) | |
| 37 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XR_001737368.1 | 54.6% | (many diffs) | |
| 38 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XR_946744.2 | 54.2% | (many diffs) | |
| 39 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XR_946742.2 | 52.8% | (many diffs) | |
| 40 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073016.3 | 49.2% | 1_188del;744_775del;1346_2286del | |
| 41 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270463.3 | 48.5% | 46.9% | (many diffs) |
| 42 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073018.3 | 47.2% | (many diffs) | |
| 43 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270464.3 | 47% | 46% | (many diffs) |
| 44 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270465.2 | 46.7% | 46% | (many diffs) |
| 45 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073017.3 | 45.8% | 1_188del;306_307ins91;1223_2163del | |
| 46 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_146867.2 | 45.3% | (many diffs) | |
| 47 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | XR_946745.2 | 44.9% | (many diffs) | |
| 48 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073019.3 | 41.1% | (many diffs) | |
| 49 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073020.3 | 39.4% | (many diffs) | |
| 50 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174967.4 | 39.1% | 36.8% | (many diffs) |
| 51 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174965.3 | 37.6% | 35.2% | (many diffs) |
| 52 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_174970.4 | 34.8% | 32.3% | (many diffs) |
| 53 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NR_073023.3 | 34.5% | 1_188del;584_585ins347;967_1907del | |
| 54 | human | 6487 | ST3GAL3 | ST3 beta-galactoside alpha-... | NM_001270466.2 | 25.1% | 23.4% | (many diffs) |
| 55 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | NM_001161774.2 | 91.9% | 97% | (many diffs) |
| 56 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | NM_001285520.1 | 91.9% | 97% | (many diffs) |
| 57 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | NM_009176.5 | 91.9% | 97% | (many diffs) |
| 58 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | NM_001285521.1 | 88% | 93.3% | (many diffs) |
| 59 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502898.3 | 88% | 93.3% | (many diffs) |
| 60 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502896.3 | 86.8% | 91.6% | (many diffs) |
| 61 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502894.1 | 85.5% | 90.3% | (many diffs) |
| 62 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502895.1 | 85.5% | 90.3% | (many diffs) |
| 63 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502897.3 | 81.9% | 86.8% | (many diffs) |
| 64 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502893.3 | 81.8% | 86.5% | (many diffs) |
| 65 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502890.3 | 81% | 85.6% | (many diffs) |
| 66 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502891.3 | 81% | 85.6% | (many diffs) |
| 67 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502892.3 | 81% | 85.6% | (many diffs) |
| 68 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XM_006502899.3 | 61.9% | 60.2% | (many diffs) |
| 69 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XR_376301.3 | 39.3% | (many diffs) | |
| 70 | mouse | 20441 | St3gal3 | ST3 beta-galactoside alpha-... | XR_376302.3 | 38.5% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1191
- ORF length:
- 1125
- Sequence:
-
1 ggtctatata agcagagctc tctggctaac tgtcgggatc aacaagtttg tacaaaaaag 61 ttggcatggg actcttggta tttgtgcgca atctgctgct agccctctgc ctctttctgg 121 tactgggatt tttgtattat tctgcgtgga agctacactt actccagtgg gaggaggact 181 ccaattcagt ggttctttcc tttgactccg ctggacaaac actaggctca gagtatgatc 241 ggttgggctt cctcctgaat ctggactcta aactgcctgc tgaattagcc accaagtacg 301 caaacttttc agagggagct tgcaagcctg gctatgcttc agccttgatg acggccatct 361 tcccccggtt ctccaagcca gcacccatgt tcctggatga ctcctttcgc aagtgggcta 421 gaatccggga gttcgtgccg ccttttggga tcaaaggtca agacaatctg atcaaagcca 481 tcttgtcagt caccaaagag taccgcctga cccctgcctt ggacagcctc cgctgccgcc 541 gctgcatcat cgtgggcaat ggaggcgttc ttgccaacaa gtctctgggg tcacgaattg 601 acgactatga cattgtggtg agactgaatt cagcaccagt gaaaggcttt gagaaggacg 661 tgggcagcaa aacgacactg cgcatcacct accccgaggg cgccatgcag cggcctgagc 721 agtacgagcg cgattctctc tttgtcctcg ccggcttcaa gtggcaggac tttaagtggt 781 tgaaatacat cgtctacaag gagagagtga gtgcatcgga tggcttctgg aaatctgtgg 841 ccactcgagt gcccaaggag ccccctgaga ttcgaatcct caacccatat ttcatccagg 901 aggccgcctt caccctcatt ggcctgccct tcaacaatgg cctcatgggc cgggggaaca 961 tccctaccct tggcagtgtg gcagtgacca tggcactaca cggctgtgac gaggtggcag 1021 tcgcaggatt tggctatgac atgagcacac ccaacgcacc cctgcactac tatgagaccg 1081 ttcgcatggc agccatcaaa gagtcctgga cgcacaatat ccagcgagag aaagagtttc 1141 tgcggaagct ggtgaaagct cgcgtcatca ctgatctaag cagtggcatc tgcccaactt 1201 tcttgtacaa agtggttggt aagcctatcc ctaaccctct cctcggtctc gattctacgt 1261 agtaatgagc tagcgctaac cggtggcgcg ttaagtcgac aatcaacctc tggatta